Top Abstract Purchase Related
Home
>
Node
>
Subnode

The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice

Matsunaga, K.; Morita, I.; Oguchi, Y.; Fujii, T.; Yoshikumi, C.; Nomoto, K.

Anticancer Research 7(3 Part B): 509-512

1987

ISSN/ISBN: 0250-7005
PMID: 3631910
Document Number: 301225
We have previously shown that oral administration of PSK not only exerts antitumor activity, but also restores immune response in tumor-bearing mice. In order to analyze the immunomodulative effect of PSK, we investigated the effects of oral PSK on the intestinal immune systems in ICR mice bearing sarcoma 180. Oral administration of PSK increased the number of Peyer's patches that developed relatively well, and led to recovered mitogenic response of lymphocytes from gut-associated lymphatic tissue and responsiveness to oral preimmunization with SRBC in tumor-bearing mice. These results suggest that PSK modulates the immunity in intestinal tract of tumor-bearing mice.

Document emailed within 1 workday
Secure & encrypted payments

Kamo, I.; Ishida, N. 1971: Immune response in tumor-bearing mice Gan 62(6): 453-458
Havas, H.F.; Berney, S.; Goodis, A.; Schiffman, G. 1979: Effect of splenectomy on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183) Cancer Research 39(9): 3783-3787
Ebina, T. 2012: Hepatic intra-arterial infusion of biological response modifier (BRM)-activated killer immune lymphocytes to treat liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 1812-1814
Sotomayor, E.M.; Fu, Y.X.; Lopez-Cepero, M.; Herbert, L.; Jimenez, J.J.; Albarracin, C.; Lopez, D.M. 1991: Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor Journal of Immunology 147(8): 2816-2823
Dimitrov, N.V.; Denny, T.N.; Weisman, M.F.; Cameron, D.G. 1979: Effect of adriamycin and Corynebacterium parvum in tumor-bearing mice: modulation of response to sheep red blood cells Journal of the National Cancer Institute 63(2): 423-426
Fujimoto, S.; Greene, M.I.; Sehon, A.H. 1976: Regulation of the immune response to tumor antigens. II. the nature of immunosuppressor cells in tumor-bearing hosts Journal of Immunology 116(3): 800-806
Iunker, V.M.; Arkhipov, S.A.; Gruntenko, E.V. 1984: Ambiguous action of splenocytes from tumor-bearing mice on the formation of metastases in the lungs of mice in an adaptive transfer system Biulleten' Eksperimental'noi Biologii i Meditsiny 98(11): 598-600
Warren, P.; Song, W.; Holle, E.; Holmes, L.; Wei, Y.; Li, J.; Wagner, T.; Yu, X. 2002: Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice Anticancer Research 22(2a): 599-604
Mao, J.-L.; Xiong, X.; Gong, H. 2019: Effects of curcumin on tumor growth and immune function in prostate cancer-bearing mice Zhonghua Nan Ke Xue 25(7): 590-594
Claflin, J.L.; Cubberley, M. 1980: Clonal nature of the immune response to phosphocholine. VII. Evidence throughout inbred mice for molecular similarities among antibodies bearing the T15 idiotype Journal of Immunology 125(2): 551-558
Shi, L.; Chen, J.; Zhong, Q.; Geng, P.; He, J. 2014: Anti-tumor effect of Sendai virus Tianjin strain defective interfering particles on tumor-bearing mice Zhonghua Zhong Liu Za Zhi 36(3): 177-182
Padarathsingh, M.L.; Mccoy, J.L.; Dean, J.H.; Lewis, D.D.; Northing, J.W.; Law, L.W. 1977: Examination of general and tumor-specific cell-mediated immune responses in mice bearing progressively growing plasmacytomas Journal of the National Cancer Institute 58(6): 1701-1707
Han, I.H.; Johnson, A.G. 1976: Regulation of the immune system by synthetic polynucleotides. VI. Amplification of the immune response in young and aging mice Journal of Immunology 117(2): 423-427
Maillard, F. 1994: Pidotimod. A new biological response modifier. Introduction Arzneimittel-Forschung 44(12a): 1399-1401
Merryman, C.F.; Maurer, P.H.; Bailey, D.W. 1972: Genetic control of immune response in mice to a glutamic acid, lysine, phenylalanine copolymer. 3. Use of recombinant inbred strains of mice to establish association of immune response genes with H-2 genotype Journal of Immunology 108(4): 937-940
Majima, H.; Nomura, K. 1986: Phase i clinical study of MY-1, a new biological response modifier Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(1): 109-115
Berman, B.; Poochareon, V.N.; Villa, A.M. 2002: Novel dermatologic uses of the immune response modifier imiquimod 5% cream Skin Therapy Letter 7(9): 1-6
Tyring, S. 2001: Imiquimod applied topically: A novel immune response modifier Skin Therapy Letter 6(6): 1-4
Tanaka, K.; Koga, Y.; Taniguchi, K.; Nomoto, K. 1987: T-cell recruitment from the thymus to the spleen in tumor bearing mice: phenotypical alteration and recruitment of thymocytes raised in a tumor bearing state Cancer Research 47(8): 2136-2141
Yue, X.F.; Wu, F.G.; Xu, B. 1982: Effect of oxalysine on plasma fibrinogen content in tumor-bearing mice Zhongguo Yao Li Xue Bao 3(2): 124-128